The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Real Estate
  • Technology
  • Entertainment
  • Education
  • Travel

GT Medical Technologies Spotlights its GammaTile® Therapy for Brain Tumors at the 2021 Congress of Neurological Surgeons (CNS)
The PennZone/10149139

Trending...
  • New Report Reveals Surprising Trends in Ohio Airport Accidents
  • Where Were the Women? Reframing the Greek Revolution Through Contemporary Art
  • IWS Press Publishes "Smart Money Shortcuts to Becoming Rich" by Tyler G. Hicks
GT Medical Technologies
Placed by a Neurosurgeon at the Time of Resection, GammaTile® Therapy Gives Patients a Head STaRT in the Fight Against Brain Tumors, Delaying Tumor Recurrence

TEMPE, Ariz. - PennZone -- GT Medical Technologies, Inc. today announced its GammaTile® Surgically Targeted Radiation Therapy (STaRT) for patients with brain tumors will be spotlighted at the 2021 CNS Annual Meeting exhibition October 18-20 in Austin, Texas, and at the 15th Tumor Section Satellite Symposium which immediately precedes it October 15-16.

"Neurological surgeons and affiliated healthcare professionals attend these prestigious events to learn about the latest advancements in neurosurgical care," said Matthew E. Likens, president and CEO of GT Medical Technologies, Inc. "We look forward to sharing our valuable data that demonstrates how GammaTile Therapy has significantly improved traditional brain tumor radiation and patient outcomes."

More on The PennZone
  • Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
  • Colony Ridge Communities Celebrates Successful Soccer Season Kickoff with Families and Youth
  • Best Companies Group Free Launches Best Places to Work in Michigan Program
  • Billy Bob Thornton & The Boxmasters Coming to The Eichelberger Performing Arts Center This August
  • NYC Composer/Educator Launches Debut Children's Book to Fantastic Reviews

Tumor Section Satellite Symposium
This two-day Symposium features engaging scientific sessions that explore technological advances in neurosurgical neuro-oncology. Attendees will have the opportunity to learn more about GammaTile Therapy in a Lunch Symposium on Saturday, October 16 at 12:15 p.m.
  • Focus: Neurosurgical Oncology
  • October 15-16 | JW Marriott, Austin Texas
  • GT Medical Technologies booth 200
  • Saturday, October 16, 12:15 PM-1:15 PM: GammaTile® Therapy: Technology and Device Overview
CNS Annual Meeting
Once a year, thousands of neurosurgeons, physicians, and affiliates from around the globe come together to attend the CNS Annual Meeting to hear about the latest technological improvements in neurosurgical treatment. This will be the first in-person conference since 2019, due to the necessity of a virtual exchange in 2020. This year, attendees can visit GT Medical Technologies at booth 1750 to learn more about GammaTile Therapy.
  • October 18-20 Exhibits | Austin Convention Center
  • GT Medical Technologies booth 1750

About GT Medical Technologies, Inc.

More on The PennZone
  • EFA Announces 2026 Editorial Rate Chart
  • Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
  • Shoutout Joseph Neibich aka Nybyk
  • Meet Joseph Neibich aka Joseph Nybyk of Beachwood Canyon
  • LARUS Launches Business Continuity Framework for IPv4-Dependent Networks

Driven to overcome the limitations of current treatments for brain tumors and raise the standard of care, a team of brain tumor specialists joined forces and formed GT Medical Technologies with the purpose of improving the lives of patients with brain tumors. Its GammaTile Therapy received FDA 510(k) regulatory clearance for the treatment of all types of recurrent brain tumors and newly diagnosed malignant tumors. Patients receive their course of radiation while going about their daily lives, requiring no additional trips to the hospital or clinic for radiation therapy. GammaTile is available in top brain tumor centers across the United States. For more information or to find a GammaTile center near you, visit https://www.gtmedtech.com/ and follow @GTMedTech on Twitter and LinkedIn.

Contact
Kate Peifer
***@brodeur.com


Source: GT Medical Technologies

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Evolve Construction Mobilizes Commercial Storm Response Across Illinois With AI-Powered Damage Documentation and Public Adjusters Partnership
  • New Book Synthesizes Six Peer-Reviewed Research Programs Into Unified Framework for Consciousness
  • The World's First Fully Regenerative Economy: Securing Energy, Food, and a Clean Planet
  • The State of Law Firm Marketing: Top Companies, Awards, and Resources
  • USA Best Book Awards Finalist What Love Leaves Behind Releases March 24
  • Inkdnylon Custom Apparel Launches Cost-Saving System for Promotional Products and Custom Apparel in Chicago
  • Colonial Nissan Helps Drivers Avoid Costly Repairs with Spring Car Maintenance Tips
  • ENTOUCH Named Finalist for 2026 North American Inspiring Workplaces Awards
  • Cleveland County Goat Farm NC Kikos Featured in "Feature Farmer Friday" Documentary
  • Tony Grundler Introduces Artificial Intelligence V.S. Avatar-Ian's
  • Hollywood's Elite Gather at the Annual WOW Creations Oscars Gifting Suite at the Universal Hilton
  • Where Were the Women? Reframing the Greek Revolution Through Contemporary Art
  • IWS Press Publishes "Smart Money Shortcuts to Becoming Rich" by Tyler G. Hicks
  • JGCMGS Details Architecture to Safeguard Assets From Unauthorized Phishing Scams
  • JEGS Launches Modern, Secure Payments Powered by PhaseZero.ai
  • 21 Days: The Malta Deadline That Could Redraw the Finnish Online Casino Map
  • U.S. Government Contracts in Excess of 38 Million Secured Through Partner, Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
  • New Report Reveals Surprising Trends in Ohio Airport Accidents
  • Why Your Berberine Failed: RevGenetics Unveils the Absorption Gap Solution
  • WCC Kitchens and Cabinets Featured on Selling Houses Australia

Popular on PennZone

  • Postmortem Pathology Expands Independent Autopsy Services Across Colorado
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • Mecpow M1: A Safe & Affordable Laser Engraver Built for Home DIY Beginners
  • Platinum Car Audio LLC Focuses on Customer-Driven Vehicle Audio and Electronics Solutions
  • Postmortem Pathology Expands Independent Autopsy Services in Kansas City
  • New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
  • $38 Million in U.S. Government Contract Awards Secured Through Strategic Partner. Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
  • Cummings Graduate Institute for Behavioral Health Studies Honors New Doctor of Behavioral Health Graduates
  • Inkdnylon Earns BBB Accreditation for Verified Business Integrity
  • IDpack v4 Launches: A Major Evolution in Cloud-Based ID Card Issuance

Similar on PennZone

  • Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
  • The AAA Metamorphosis: How Global Gaming Is Redefining Production Standards
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
  • Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
  • Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
  • Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
  • New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
  • Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
  • Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
  • Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us